Phase 1 Trial of Allogeneic Gene-Modified Tumor Cell Vaccine RCC-26/CD80/IL-2 in Patients with Metastatic Renal Cell Carcinoma
2010 ◽
Vol 21
(3)
◽
pp. 285-297
◽
Alexander Buchner
◽
Heike Pohla
◽
Gerald Willimsky
◽
Bernhard Frankenberger
◽
Ronald Frank
◽
...
2007 ◽
Vol 6
(2)
◽
pp. 265
A. Buchner
◽
H. Pohla
◽
A. Baur
◽
J. Kopp
◽
A. Pezzutto
◽
...
2008 ◽
Vol 179
(4S)
◽
pp. 412-412
Alexander Buchner
◽
Heike Pohla
◽
Bernhard Frankenberger
◽
Andrea Baur
◽
Christian G Stief
◽
...
2019 ◽
Vol 125
(7)
◽
pp. 1124-1132
◽
Sumanta K. Pal
◽
Andres Forero‐Torres
◽
John A. Thompson
◽
John C. Morris
◽
Saurabh Chhabra
◽
...
2011 ◽
Vol 118
(7)
◽
pp. 1868-1876
◽
Ana M. Molina
◽
Darren R. Feldman
◽
Martin H. Voss
◽
Michelle S. Ginsberg
◽
Michael S. Baum
◽
...
2002 ◽
Vol 5
(5)
◽
pp. S123-S124
2000 ◽
Vol 6
(4)
◽
pp. 199-205
◽
Nobuyasu Nishisaka
◽
Richard F Jones
◽
Philo Morse
◽
Katsuyuki Kuratsukuri
◽
Rianna Romanowski
◽
...
Li Shen
◽
Ashley Orillion
◽
Remi Adelaiye
◽
Eric Ciamporcero
◽
Swathi Ramakrishnan
◽
...
2004 ◽
Vol 171
(4S)
◽
pp. 435-435
Christian Doehn
◽
Axel Richter
◽
Walter Lehmacher
◽
Dieter Jocham